PHENTERMINE-TOPIRAMATE ER 3.75-23 MG CAPSULE

Phentermine and topiramate
$2.9549per EA
DEA Schedule CIV

Strength

3.75; 23 mg/1; mg/1

NDC

00480329756

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA204982

On Market Since

5/7/2025

Pharmacological Classes

Appetite Suppression
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Increased Sympathetic Activity
Sympathomimetic Amine Anorectic

Price History

1W

0.0%

1M

+3.8%

3M

-13.1%

6M

+1.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

+12.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.